Stock Spotlight: UnitedHealth Group Inc (NYSE:UNH)

About UnitedHealth Group Inc

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

Key Stats

Source: Yahoo Finance. Data as of 15/08/25.

Growth Potential

• Change in management could lead to a reset in earnings and growth expectations.
• Medical costs are evidently elevated at the moment, putting pressure on the broader industry – some suggest costs could be playing catch up from Covid-driven disruptions (deferred care).
• Potential Justice Department adds to near-term risk.
• Change in the new patient codes is causing disruption – the Biden administration implemented a new coding system (V28) that removed or lowered the weighting on certain conditions. This has led to a hit to revenue for insurers – e.g. U.S. listed Humana Inc called out an impact of ~1.6% to its revenue line for 2025 due to the rule changes. 
• Optum is also experiencing cost pressure due to new patients being more complex and requiring intensive care. 
• The aggressive sell off in UNH’s share price should find a floor if management can show some signs of stabilization over the coming months. Some increased insider buying activity in the recent sell off.
• Management believes they can return to the target range in 2026 and reiterated their long-term EPS growth target range of 13-16%.

Key Risks

• Ongoing cost pressures.
• Headwinds from potential regulatory reforms like Medicare for all.
• Value destructive M&A.
• Key-man risk due to management changes.
• Increased competition (pricing pressure & innovative products) from new entrants or existing players like Anthem and Humana.
• Cyber-attacks or other privacy or data security incidents resulting in security breaches.
• Legal proceedings leading to substantial penalties or damage to reputation.